Home > Healthcare > Medical Devices > Medical Supplies > Nasal Cannula Market

Nasal Cannula Market Trends

Report ID: GMI4548
Published Date: Nov 2023
Report Format: PDF

Download Free Sample

Nasal Cannula Market Trends

The increasing home healthcare adoption of nasal cannulas reflects a broader trend towards patient-centred care, emphasizing comfort, accessibility, and cost-effectiveness. As technology and healthcare delivery models continue to evolve, the role of nasal cannulas in home-based respiratory care is anticipated to expand further.

The development of portable and user-friendly nasal cannula devices has facilitated their use in home settings. Compact and battery-operated options provide patients with greater mobility and independence.
Home healthcare, including the use of nasal cannulas, is often more cost-effective than prolonged hospitalization. The shift towards home-based care helps optimize healthcare resources and reduces the burden on hospital facilities.
The COVID-19 pandemic accelerated the adoption of home healthcare solutions, including nasal cannulas. Concerns about infection risks in healthcare settings prompted a preference for home-based care whenever feasible.
Educational efforts by healthcare providers have empowered patients to manage their respiratory conditions at home. Training programs and informational resources on the proper use of nasal cannulas have contributed to increased adoption.

Authors: Mariam Faizullabhoy

Frequently Asked Questions (FAQ) :

Nasal cannula industry was worth USD 7.5 billion in revenue in 2022 and is projected to reach USD 13.5 billion by 2032 driven by the aging population base with higher prevalence of respiratory issues and the increase in complex surgical interventions.

Low flow segment garnered USD 5.4 billion in revenue in 2022 and is estimated to witness high demand through 2032 attributed to widespread usage in chronic conditions, such as chronic obstructive pulmonary disease (COPD) and sleep apnea.

U.S. nasal cannula market size exceeded USD 2.9 billion in 2022 and is poised to exhibit robust growth rate through 2032 owing to the rising changes in healthcare policies, reimbursement structures, and insurance coverage.

Some of the top nasal cannula companies are Salter Labs, Teleflex Incorporated, Becton, Dickinson and Company, Westmed, Inc., Flexicare Medical Limited, Smiths Medical, Medtronic PLC, Sorin Group, and Masimo Corporation.